What is the role of upfront pembrolizumab in metastatic PD-L1 positive NSCLC presenting with SVC syndrome?
Would starting with chemotherapy be preferred in this situation and consider concurrent radiation, then switch over to Pembrolizumab once some control is achieved?
Community PollStarted
What therapy do you recommend for metastatic PD-L1 positive NSCLC presenting with SVC syndrome after placement of stent?
94 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Albert Einstein College of Medicine at Montefiore Medical Center
Answered on
This is a "trick question" as there are at least 3 difficult questions hidden here-
- Can systemic therapy replace the need for local therapy in urgent clinical situations traditionally calling for radiation?
- What is the best upfront treatment regimen for a patient with PD-L1 positive NSCLC?
- What is t...
Join for free or sign in to see the full answer